Expanding the indications for sentinel lymph node surgery in breast cancer

Future Oncology

Volumn 3, Issue 1, 2007, Pages 9-14

  Boughey, Judy C ^a   Hunt, Kelly K ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ISOSULFAN BLUE; METHYLENE BLUE;

ACCURACY; ADJUVANT CHEMOTHERAPY; ASPIRATION BIOPSY; BREAST CANCER; BREAST SURGERY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; EDITORIAL; FEASIBILITY STUDY; HUMAN; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MALE BREAST; MASTECTOMY; MEDICAL DECISION MAKING; NEEDLE BIOPSY; PREGNANCY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SENTINEL LYMPH NODE; SEX DIFFERENCE; SURGICAL TECHNIQUE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME;

BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; HUMANS; INFLAMMATION; LYMPH NODES; MALE; MASTECTOMY; NEOADJUVANT THERAPY; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; SENTINEL LYMPH NODE BIOPSY;

EID: 33847083958     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/14796694.3.1.9     Document Type: Editorial

References (43)

1. Krag DN, Weaver DL, Alex JC et al.: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg. Oncol. 2, 335-339; discussion 340 (1993).
2. Giuliano AE, Kirgan DM, Guenther JM et al.: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann. Surg. 220, 391-398; discussion 398-401 (1994).
3. Lucci A, Mackie L, Beitsch P et al.: Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection, versus SLND alone in The American College of Surgeons Oncology Group (ACOSOG) Trial Z0011. Ann. Surg. Oncol. 13, 4 (2006).
4. Wilke LG, McCall LM, Posther KE et al.: Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann. Surg. Oncol. 13, 491-500 (2006).
5. Hill AD, Bergen PI, Cody HS 3rd: Sentinel node biopsy in male breast cancer. Eur. J. Surg. Oncol. 25, 442-443 (1999).
6. Port ER, Fey JV, Cody HS 3rd et al.: Sentinel lymph node biopsy in patients with male breast carcinoma. Cancer 91, 319-323 (2001).
7. Boughey JC, Bedrosian I, Meric-Bernstam F et al.: Comparative analysis of sentinel lymph node operation in male and female breast cancer patients. J. Am. Coll. Surg. 203, 475-480 (2006).
8. Cimmino VM, Degnim AC, Sabel MS et al.: Efficacy of sentinel lymph node biopsy in male breast cancer. J. Surg. Oncol. 86, 74-77 (2004).
9. Goyal A, Horgan K, Kissin M et al.: Sentinel lymph node biopsy in male breast cancer patients. Eur. J. Surg. Oncol. 30, 480-483 (2004).
10. Boughey JC, Ross MI, Babiera GV et al.: Sentinel lymph node surgery in locally recurrent breast cancer. Clin. Breast Cancer 7, 248-253 (2006).
11. Port ER, Fey J, Gemignani ML et al.: Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma. J. Am. Coll. Surg. 195, 167-172 (2002).
12. Taback B, Nguyen P, Hansen N et al.: Sentinel lymph node biopsy for local recurrence of breast cancer after breast-conserving therapy. Ann. Surg. Oncol. 13, 1099-1104 (2006).
13. Roumen RM, Kuijt GP, Liem IH: Lymphatic mapping and sentinel node harvesting in patients with recurrent breast cancer. Eur. J. Surg. Oncol. 32(10), 1076-1081 (2006).
14. Garcia-Etienne CP, Fey J, Borgen P, Cody HS, Port ER: Prior axillary surgery is not a contraindication to sentinel lymph node biopsy: results of reoperarive sentinel lymph node biopsy in 133 patients. Ann. Surg. Oncol. 13, 9 (2006).
15. Milardovic R, Castellon I, Mills C et al.: Scintigraphic visualization of an epigastric sentinel node in recurrent breast cancer after lumpectomy and postoperative radiation therapy. Clin. Nucl. Med. 31, 207-208 (2006).
16. Boughey JC, Khakpour N, Meric-Bernstam F et al.: Selective use of sentinel lymph node surgery during prophylactic mastectomy. Cancer 107, 1440-1447 (2006).
17. Black DS, Specht M, Lee JM et al.: Detecting occult breast cancer in prophylactic mastectomies: sentinel node biopsy vs pre-operative MRI. Ann. Surg. Oncol. 13, 9 (2006).
18. Kumar R, Potenta S, Alavi A: Sentinel lymph node biopsy in multifocal and multicentric breast cancer. J. Am. Coll. Surg. 198, 674-676 (2004).
19. Tousimis E, Van Zee KJ, Fey JV et al.: The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers. J. Am. Coll. Surg. 197, 529-535 (2003).
20. Ozmen V, Muslumanoglu M, Cabioglu N et al.: Increased false negative rates in sentinel lymph node biopsies in patients with multi-focal breast cancer. Breast Cancer Res. Treat. 76, 237-244 (2002).
21. Fernandez K, Swanson M, Verbanac K et al.: Is sentinel lymphadenectomy accurate in multifocal and multicentric breast cancer. Ann. Surg. Oncol. 9, S16-S17 (2002).
22. Jin Kim H, Heerdt AS, Cody HS et al.: Sentinel lymph node drainage in multicentric breast cancers. Breast J. 8, 356-361 (2002).
23. Schrenk P, Wayand W: Sentinel-node biopsy in axillary lymph-node staging for patients with multicentric breast cancer. Lancet 357, 122 (2001).
24. Veronesi P, Intra M, Vento AR et al.: Sentinel lymph node biopsy for localised ductal carcinoma in situ? Breast 14, 520-522 (2005).
25. Camp R, Feezor R, Kasraeian A et al.: Sentinel lymph node biopsy for ductal carcinoma in situ: an evolving approach at the University of Florida. Breast J. 11, 394-397 (2005).
26. Yen TW, Hunt KK, Ross MI et al.: Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J. Am. Coll. Surg. 200, 516-526 (2005).
27. Gentilini O, Cremonesi M, Trifiro G et al.: Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann. Oncol. 15, 1348-1351 (2004).
28. Keleher A, Wendt R 3rd, Delpassand E et al.: The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Byrast J. 10, 92-95 (2004).
29. Pandit-Taskar N, Dauer LT, Montgomery L et al.: Organ and fetal absorbed dose estimates from 99mTc-sulfur colloid lymphoscintigraphy and sentinel node localization in breast cancer patients. J. Nucl. Med. 47, 1202-1208 (2006).
30. Reitsamer R, Peintinger F, Rettenbacher L et al.: Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. J. Surg. Oncol. 84, 63-67 (2003).
31. Breslin TM, Cohen L, Sabin A et al.: Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J. Clin. Oncol. 18, 3480-3486 (2000).
32. Mamounas EP, Brown A, Anderson S et al.: Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J. Clin. Oncol. 23, 2694-2702 (2005).
33. van Rijk MC, Nieweg OE, Rutgers EJ et al.: Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer patients axillary lymph node dissection. Ann. Surg. Oncol. 13, 475-479 (2006).
34. Newman ES, Diehl KM, Cimmino VM et al.: Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive disease at presentation. Ann. Surg. Oncol. 13, 10 (2006).
35. Heuts EM, van der Ent FW, Kengen RA et al.: Results of sentinel node biopsy not affected by previous excisional biopsy. Eur. J. Surg. Oncol. 32, 278-281 (2006).
36. Haigh PI, Hansen NM, Qi K et al.: Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann. Surg. Oncol. 7, 21-27 (2000).
37. Luini A, Galimberti V, Gatti G et al.: The sentinel node biopsy after previous breast surgery: preliminary results on 543 patients treated at the European Institute of Oncology. Breast Cancer Res. Treat. 89, 159-163 (2005).
38. Jakub JW, Ebert MD, Cantor A et al.: Breast cancer in patients with prior augmentation: presentation, stage, and lymphatic mapping. Plast. Reconstr. Surg. 114, 1737-1742 (2004).
39. Gray RJ, Forstner-Barthell AW, Pockaj BA et al.: Breast-conserving therapy and sentinel lymph node biopsy are feasible in cancer patients with previous implant breast augmentation. Am. J. Surg. 188, 122-125 (2004).
40. Golshan M, Lesnikoski BA, Lester S: Sentinel lymph node biopsy for occult breast cancer detected during breast reduction surgery. Am. Surg. 72, 397-400 (2006).
41. Schrenk P, Wolfl S, Bogner S et al.: Symmetrization reduction mammaplasty combined with sentinel node biopsy in patients operated for contralateral breast cancer. J. Surg. Oncol 94, 9-15 (2006).
42. Bedrosian I, Reynolds C, Mick R et al.: Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer 88, 2540-2545 (2000).
43. Stearns V, Ewing CA, Slack R et al.: Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann. Surg. Oncol. 9, 235-242 (2002).